GD-ZIPRASIDONE 20 MG
ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) : 20 MG · DIN 02441357 · GENMED A DIVISION OF PFIZER CANADA ULC
Health Canada status: CANCELLED PRE MARKET
What is GD-ZIPRASIDONE?
GD-ZIPRASIDONE 20 MG contains ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 02441357, held by GENMED A DIVISION OF PFIZER CANADA ULC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled pre market, status dated 13-Oct-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02441357 |
|---|---|
| Brand name | GD-ZIPRASIDONE |
| Generic / active ingredient | ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE) : 20 MG |
| Manufacturer | GENMED A DIVISION OF PFIZER CANADA ULC |
| Strength | 20 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N05AE04 ZIPRASIDONE |
| AHFS class | 28:16.08.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 13-Oct-2020 |
What can be used instead?
Other Canadian products sharing ATC code N05AE04 ZIPRASIDONE. 8 of 20 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AURO-ZIPRASIDONE | 20 MG | CAPSULE | AURO PHARMA INC | MARKETED | DIN 02449544 |
| AURO-ZIPRASIDONE | 40 MG | CAPSULE | AURO PHARMA INC | MARKETED | DIN 02449552 |
| AURO-ZIPRASIDONE | 60 MG | CAPSULE | AURO PHARMA INC | MARKETED | DIN 02449560 |
| AURO-ZIPRASIDONE | 80 MG | CAPSULE | AURO PHARMA INC | MARKETED | DIN 02449579 |
| ZELDOX | 20 MG | CAPSULE | BGP PHARMA ULC | MARKETED | DIN 02298597 |
| ZELDOX | 40 MG | CAPSULE | BGP PHARMA ULC | MARKETED | DIN 02298600 |
| ZELDOX | 60 MG | CAPSULE | BGP PHARMA ULC | MARKETED | DIN 02298619 |
| ZELDOX | 80 MG | CAPSULE | BGP PHARMA ULC | MARKETED | DIN 02298627 |
| GD-ZIPRASIDONE | 40 MG | CAPSULE | GENMED A DIVISION OF PFIZER CANADA ULC | CANCELLED PRE MARKET | DIN 02441365 |
| GD-ZIPRASIDONE | 60 MG | CAPSULE | GENMED A DIVISION OF PFIZER CANADA ULC | CANCELLED PRE MARKET | DIN 02441373 |
Who else supplies ZIPRASIDONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ZIPRASIDONE appears in 138 registered pack listings across 11 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.